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1. Introduction
  Plumbago zeylanica(P. zeylanica), commonly known as 
white chitrak (Family: Plumbaginaceae) is a perennial 
herb that is grown in most part of India and is used in the 
traditional system of Indian medicine against a number of 
ailments including skin disease, abdomen enlargement, 
anemia, diabetes, leprosy, dyspepsia, elephantiasis, 
diarrhea and leprosy[1]. The pharmacological studies carried 
out by several workers indicate that P. zeylanica Linn. 
possesses astringent, diuretic, antibacterial, antifungal, 
anticarcinogenic, antitumor and radiomodifying properties. 
The roots of this plant has been reported to be a powerful 
poison when given orally or applied to ostium uteri, causes 
abortion[2]. Plumbagin, a crystalline naphthoquinone 
compound isolated from root extract has shown antifertility 
activity but was found to be toxic. The preliminary studies 
on the plumbagin free alcohol extract of the root showed 
antifertility activity devoid of adverse reactions[3]. However, 
the exact mechanism of antifertility action is still not known. 
The present study was, therefore, carried out to confirm the 
exact mechanism of antifertility action in female rats using 
different models, and to determine its oral LD50. 
2. Materials and methods
2.1. Plant material
  The plant specimens for the study were collected 
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in December 2008 from Government Agriculture 
College, Bilaspur (Chhattisgarh, India) 22°06’35.83”N 
and 82°08’06.23”E and were positively identified and 
authenticated by the Botanist Dr. Shiddamallayya N, 
Regional Research Institute (Ay.), Central council for 
research in Ayurveda and Siddha, Ashoka pillar, Jayanagar, 
Bangalore. A voucher specimen No. is (RRCBI/Mus.5-18), 
Reference No. (RRI/BNG/SMP/Drug Authentication/2008-
09/957), dated 28/02/2009. Care was taken to select healthy 
fully grown plant with normal organs. The samples of root 
were cut suitably and removed from the plant and thoroughly 
washed with water to remove the adherent impurities. Then 
the roots were shade dried, pulverized to a coarse powder in 
a mechanical grinder, passed through a 40-mesh sieve. 
2.2. Preparation of PFAE
  Plumbagin was freed from the root by Soxhlet extraction 
with petroleum ether (60-80℃), then re-extracted with 
ethyl alcohol. The extract obtained contained only traces 
of plumbagin which were removed by further extraction 
with petroleum ether (60-80℃). The extract obtained was 
decanted, and concentrated at reduced pressure below 40℃ 
through rotary evaporator to obtain dry extract (19.56%). 
A suspension of this was prepared in distilled water using 
Tween-80 (1%).
2.3. Phytochemical screening
  Phytochemical tests of PFAE of P. zeylanica Linn. root were 
carried out following the methods of Kokate[4]. Thin-layer 
chromatography studies were carried out following Wagner 
et al[5] to confirm the absence of plumbagin. The standard 
plumbagin was obtained from Hi Media, Mumbai, India. 
Silica gel 60 F254 pre coated sheets (E. Merck, Mumbai, 
India) was used as adsorbent. The plates were developed 
using chloroform: methanol (93:7) as mobile phase, in a 
Camag twin trough chamber to a distance of 8 cm each and 
iodine vapor was taken as a viewing medium.
2.4. Animals
  Wistar albino rats of either sex were used for this study. 
The animals were procured and housed in the animal house 
of School of Pharmacy, Chouksey Engineering College, 
Bilaspur (Chhattisgarh). Six rats were taken for each group. 
The rats were acclimized to the laboratory environment for 7 
days prior to the study. Animal house was well maintained 
under standard hygienic condition at (26依2)℃, relative 
humidity of 44%-55%, 12 h day and night cycle, and with 
food and water ad libitum. The animal experiment was 
performed as per Committee for the Purpose of Control 
and Supervision of Experiments on Animals norms after 
obtaining Institutional Animal Ethics Committee clearance.
2.5. Acute oral toxicity studies
  Acute toxicity studies were carried out following Ghosh [6] to 
study the acute toxic effects and to determine the minimum 
lethal dose of the drug extracts. Swiss albino rats of either 
sex were used for the study. The alcohol and aqueous 
extracts were administered orally to overnight fasted animals 
at doses of 30, 100, 300, 1 000, 2 000 and 5 000 mg/kg of body 
weight (bw). After administration of the extracts, the animals 
were observed individually for mortality and clinical signs of 
toxicity.
2.6. Study of estrous cycle
  Matured female Wistar albino rats (200-210 g) having regular 
estrous cycle were divided into three groups consisting of 
six animals in each group. One group served as control and 
received vehicle orally for 21 days. The other two groups 
received PFAE at a dose of 300 and 500 mg/kg bw/day
respectively for 21 days. The estrous cycle was determined 
by stained preparation of vaginal smear of the animals[7]. 
After 21 days of treatment, extract was withdrawn from the 
rats and estrous cycle was studied for another 21 days, ie., 
post-extract period. 
2.7. Study of reproductive outcome in rat
  Three groups of mature female rats (six rats/group) were 
selected as mentioned above. Two groups received PFAE 
for 8 days and control group received vehicle for the same 
period. All the experimental rats were then allowed to mate 
with mature fertile male rats and the treatment continued 
for 21 days. The number of litters was determined and 
compared after the completion of one gestation period. 
The reversibility of antifertility effect of the extract was 
also studied. For this study, the extract was administered 
continuously for 21 days and then the extract was withdrawn. 
After 21 days of extract withdrawal, animals were allowed to 
mate with male rats. The number of litters was determined 
after the completion of one gestation period[7].
2.8. Postcoital antifertility activity
  Wistar strain female albino rats (150-200 g) of proven 
fertility and regular estrous cycle were caged with males of 
proven fertility in a ratio of 2:1. The females were examined 
the following morning for evidence of copulation. The 
animals, which showed thick clumps of spermatozoa in the 
vaginal smears, were separated and that day was designated 
as day 1 of pregnancy. The suspension of PFAE were 
administered orally through intragastric catheter from day 1 
to 7 of pregnancy at 300 and 500 mg/kg bw, respectively to 
different groups of pregnant rats. Control animals received 
the vehicle (Tween-80, 1%, p.o.) only. The animals were 
laparotomised under light ether anesthesia and semi-sterile 
conditions on day 10 of pregnancy. Both horns of the uterus 
were observed for the number and size of implants. The rats 
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were allowed to recover and deliver after full term. Each 
fetus was weighed and examined for gross defects. The 
litters were allowed to grow to check their postnatal growth 
and monitor any congenital abnormalities[8].
2.9. Abortifacient activity
  Rats at day 1 of pregnancy were divided into three groups, 
consisting of six animals in each group. The first group 
served as control and received vehicle only (Tween-80, 1%,) 
and group 2-3 received suspension of PFAE of P. zeylanica 
root (300 and 500 mg/kg) in 1% Tween-80, respectively from 
day 10 to 18 of pregnancy. During the experiment animals 
were observed for vaginal bleeding. On 21st day, animals 
were laparotomised under light ether anesthesia and 
observed for number of litters and percentage of resorption 
compared with initial number of implantation on 10th day of 
pregnancy[9].
2.10. Estrogenic and antiestrogenic activity
  PFAE at 500 mg/kg bw was found to be the most active in 
the post-coital antifertility testing. Hence, it was subjected 
to a detailed investigation for potential estrogenic and 
antiestrogenic activity. The uterine weight and vaginal 
cornification method was employed for this assay. Colony-
bred immature ovariectomised female albino rats (Wistar 
strain), 21-23 days old and weighing between 30 and 40 g 
were used. They were divided into four groups consisting 
of eight animals in each group. The first group served as 
control and received the vehicle only (Tween-80, 1%). The 
second group received a suspension of ethinyl estradiol 
(Unicure Remedies Pvt. Ltd., Baroda, India) in distilled 
water using Tween-80, (1%) at a dose of 0.02 mg/kg bw. 
The third group received the PFAE at 500 mg/ kg bw and 
the fourth group received, in addition to 0.02 mg/kg bw of 
ethinyl estradiol, a test dose of PFAE at 500 mg/kg bw. All 
the above treatments were given orally for 7 days. Body 
weights and vaginal smears were recorded daily. Positive 
smears were those containing nucleated or cornified cells 
and not more than a few leucocytes. 
  On the 8th day of the experiment, all the animals were 
sacrificed by decapitation under light ether anesthesia and 
the uteri were dissected out, surrounding tissues removed, 
blotted on filter paper and weighed quickly on balance 
sensitive to 0.000 1 g. A portion of the uterine tissues and 
adrenal glands from the control and treated animals were 
fixed in Bouin’s fluid for 24 h, dehydrated in alcohol and 
then embedded in paraffin. The paraffin blocks were 
sectioned at 6 mm intervals and stained with haematoxylin-
eosin for histological examinations. The other portion of the 
uterus was homogenized with ice-cold distilled water in a 
pre-cooled mortar and pestle to contain 10 mg of tissue/mL.
The homogenate was centrifuged in cold at 3 000 rpm for 
15 min and the supernatant was used for the estimation of 
glucose, cholesterol and alkaline phosphatase using the 
standard methods[10].
2.11. Quantitative determination of hormones
  The serum progesterone, follicle stimulating hormone 
(FSH), luteinizing hormone (LH) and prolactin were 
quantitatively determined following the procedure outlined 
in the manufacturer’s protocol version which adopted the 
principle of Tietz[11] using ELISA kit (Kruise Pathline, 
Ahmedabad, India). Protein concentration of the homogenate 
was determined using the biuret method[12].
2.12. Toxicological investigations
  Blood samples of each animal were collected by cardiac 
puncture. Haematological parameters were recorded[13]. 
Biochemical parameters were also estimated using reagent 
kits (Span Diagnostics, Surat, India).
2.13. Statistical analysis
  All values are expressed as mean依SEM. Means were 
statistically analyzed by one-way analysis of variance 
(ANOVA), and values of P<0.05 were considered statistically 
significant.
3. Results
3.1. Phytochemical screening
  Phytochemical studies revealed the presence of glycosides, 
terpene and tannin. TLC of extract revealed the presence 
of four spots at Rf 0.06, 0.13, 0.22, 0.31 with no spot 
corresponding to that of plumbagin reference standard (Rf 
0.66). The most prominent spot is at Rf 0.06.
3.2. Acute oral toxicity studies
  Acute toxicity studies were carried out to evaluate toxicity 
and to determine the minimum lethal dose of the drug 
extracts, using Swiss albino rats. No mortality as well as any 
clinical sign of toxicity has been observed at a dose level 
of 5 000 mg/kg indicating that all the extracts comes under 
category 5 or unclassified according to Globally Harmonized 
Classification System, and hence, LD50 cut-off was found to 
be 5 000 mg/kg bw. Hence, one-tenth of this dose, i.e. up to 
500 mg/kg bw, was used for antifertility investigation.
3.3. Effect of the extract on the estrous cycle and reproductive 
outcome
  Treatment of rats with extract of 300 and 500 mg/kg bw 
for 21 days caused  a dose dependent prolonged estrus 
cycle with significant  increase in the duration of diestrus 
phase(P<0.01) (Table 1). A dose dependent decrease was 
observed in case of number of litters produced, however 
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both the post treatment groups indicated an increase in the 
number of litters.
3.4. Postcoital antifertility activity
  Anti-implantation activity is calculated as the percentage 
of animals indicating the absence of implantations in 
the uteri when laparatomy was performed on day 10 of 
pregnancy (Table 2). A significant anti-implantation 
activity was observed in a dose dependent manner(P<0.01). 
All treatments significantly reduced the number of litters 
born confirming the antifertility activity of PFAE(P<0.01). 
None of the treatments altered the number of corpora lutea, 
which was similar to that of the controls.  The number of 
rats without implantation on day 10 was 0 in control group 
(0.00%), 2 in 300 mg/kg bw PFAE group (33.33%), and 3 in 
500 mg/kg bw PFAE group (50.00%).
3.5. Abortifacient activity
  A dose dependent abortifacient response was confirmed 
by the number of implants versus number of litters with 
Table 1
Effect of PFAE on the estrous cycle of rat for 21 days and number of litters produced in different groups of rat (mean依SEM, n=6).
Groups
Observation parameters
Duration of 
cycle (days)
Proestrus phase
 (days) 
Estrus phase
 (days)
Metestrus 
phase (days)
Diestrus phase
 (days)
No. of litters
Control   4.66依0.16   0.93依0.04 0.95依0.09 0.87依0.05   1.91依0.09 7.66依0.33
PFAE treatments 300 mg/kg bw/d   5.95依0.24*   0.51依 0.15* 1.21依0.08 0.56依0.03   3.67依0.12** 4.16依0.31**
Post-treatment of 300 mg/kg bw/d   4.65依0.38   0.87依0.17 1.11依0.22 0.81依0.15   1.86依0.22 7.16依0.47
500 mg/kg bw/d   5.91依0.56*   0.42依0.06** 1.37依0.11   0.45依0.08*   3.76依0.08** 2.66依0.33**
Post-treatment of 500 mg/kg bw/d   4.83依0.32   0.41依 0.01** 1.31依0.08 0.73依0.09   2.38依0.14 5.83依0.61*
Data are analysed one-way ANOVA followed by Dunnet multiple comparison test. * P<0.05, ** P <0.01, significantly different from control.
Table 2
Postcoital antifertility activity of PFAE (mean依SEM, n=6).
Treatment Dose(mg/kg bw) No. of implantation sites No. of corpora lutea Total litter size 
Control -   9.00依0.26 9.16依0.16 9.16依0.31
PFAE 300     6.50依0.23** 8.83依0.31     4.16依0.47**
PFAE 500     5.16依0.41** 8.33依0.33     3.33依0.42**
Data are analysed one-way ANOVA followed by Dunnet multiple comparison test.  ** P <0.01, significantly different from control.
Table 3
Abortifacient activity of PFAE (mean依SEM, n=6).
Treatment Dose(mg/kg bw) No. of implantation sites Total litter size 
Control - 6.66依0.62    6.50依0.43
PFAE 300 5.66依0.98      4.33依0.49*
PFAE 500 5.83依0.41       3.50依0.81**
Data are analysed one-way ANOVA followed by Dunnet multiple comparison test.  * P <0.05, ** P <0.01, significantly different from control.
Table 4
Histological changes in the uterus and endometrium after treatment with PFAE (mean依SEM, n=6).
Treatment Dose(mg/kg bw) Diameter of uterus(毺m) Thickness of endometrium (毺m) Height of endometrium epithelium (毺m)
Control -  331.42依8.75 202.15依4.59 12.49依2.91
Ethinyl estradiol 0.02           819.3依13.14△△       382.34依7.35△△       44.44依 3.72△△
PFAE 500 308.12依9.26 190.35依3.95 11.08依1.51
Ethinyl estradiol + PFAE 0.02+500          501.95依4.97**△△           286.46依5.48**△△         29.61依3.07*△△
Data are analysed one-way ANOVA followed by Tukey multiple comparison test. △△P <0.001, significantly different from control. * P <0.01,
 ** P <0.001, significantly different from ethinyl estradiol.
Table 5
Biochemical changes in the uterus after treatment with PFAE (mean依SEM, n=6).
Treatment Dose(mg/kg bw) Glucose (mg/100 g) Cholesterol (mg/100 g) Alkaline phosphatase (IU/100 g)
Control - 0.98依0.03 5.68依0.08 0.63依0.07
Ethinyl estradiol 0.02 1.52依0.06△△ 7.81依0.23△△ 0.98依0.04△△
PFAE 500 0.93依0.05 5.67依0.05 0.57依0.01
Ethinyl estradiol + PFAE 0.02+500 1.12依0.06**△△ 5.96依0.12**△△ 0.68依0.02**△△
Data are analysed one-way ANOVA followed by Tukey multiple comparison test.  △△ P <0.001, significantly different from control, 
** P <0.001, significantly different from ethinyl estradiol.
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2% resorption in control group, 40% at 500 mg/kg bw dose, 
and 23% at 300 mg/kg bw dose. All treatments significantly 
reduced the number of litters born  indicating the 
antifertility activity of PFAE (Table 3) (P<0.01). 
3.6. Estrogenic and antiestrogenic activity
  Oral administration of the extract alone at 500 mg/kg bw 
did not show any significant changes in uterine weight 
[(70.48依2.13) mg/100 g bw vs. (67.31依1.51) mg/100 g bw] 
and uterine content of glucose, cholesterol and alkaline 
phosphatase compared with control group. The vagina 
remained closed and cornification was not induced (versus 
control). The uterotrophic changes such as diameter 
of the uterus, thickness of endometrium and height of 
endometrial epithelium were also insignificantly changed 
(versus control)(Table 4). A highly significant increase in 
the uterine weight[(312.36依5.24) mg/100 g bw] and uterine 
contents was observed in estrogen treated group (P<0.001) 
(Table 5). However, co-administration of ethinyl estradiol 
and extract caused a highly significant (P<0.001) decrease in 
uterine weight[(218.18依1.97) mg/100 g bw]  when compared 
to estrogen treated group. The uterotropic changes were also 
significantly decreased (versus standard, P<0.001) (Table 
4). A significant decrease in the uterine content of glucose, 
cholesterol and alkaline phosphatase was also observed 
(versus standard, P<0.001) (Table 5). Vaginal opening and 
cornification were also reduced as compare to estrogen 
treated group. 
3.7. Hormonal analysis
  The extract dose dependently decreased the concentration 
of serum progesterone, FSH and LH, while a dose dependent 
increase was observed in the concentration of serum 
prolactin (Figure 1).
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Figure 1. Effect of administration of PFAE between Days 18 and 20 
of pregnancy on some reproductive hormones of female rats.                              
* P <0.05, ** P <0.01,  significantly different from control.
3.8. Txicological investigation
  Biochemical parameters in the serum/blood and 
haematological parameters did not show appreciable 
changes throughout and after the course of investigation 
Table 6
Blood/serum biochemical profile of control and experimental female rats treated with PFAE (mean依SEM, n=6).
Group Dose
(mg/kg bw)
Protein
(g/dL)
Albumin
(g/dL)
Glucose
(mg/dL)
SGOT
(IU/L)
SGPT
(IU/L)
Cholesterol
 (mg/dL)
ALP
(U/L)
Creatinine
(mg/dL)
Control - 7.13依0.27 3.10依0.24 110.22依5.27 104.0依 6.76 85.99依4.51 130.01依3.27 328.69依5.68 0.71依0.10
Extract 300 6.41依0.11 2.91依0.10 102.08依5.25 111.24依3.21 87.28依6.21 97.09依1.15 311.10依4.12 0.52依0.12
Extract 500 6.98依0.31 3.23依0.12 104.13依5.91 96.11依4.32 82.26依4.27 108.02依1.19 302.15依5.12 0.65依0.04
Post-extract (30 days) 300 6.40依0.12 2.80依0.12 112.08依5.15 109.14依2.22 89.20依7.21 107.14依1.15 320.12依2.12 0.50依0.11
Post-extract(30 days) 500 6.80依0.22 3.18依0.10 108.12依9.21 94.12依3.22 78.16依5.28 118.12依2.10 312.11依4.12 0.63依0.02
Table 7
Haematological profile of control and experimental female rats treated with PFAE (mean依SEM, n=6).
Group Dose
(mg/kg bw)
RBC
(106/毺L)
WBC
(103/毺Ll)
Hb
(g/dL)
PCV
(%)
MCHC
(%)
Clotting
time(Sec.)
Platelet
(103/毺L)
Differential leukocyte count
N(%) B(%) L(%) M(%) E(%)
Control - 7 . 7 0 依
0.39
14.55依5.78 15.03依
0.96
50.00依
3.68
32.18依
3.44
150.19依
12.83
4 5 0 . 8 6 依
60.29 20.50依0.22 0.25依0.19 75.08依6.38 1.75依0.27 1.25依2.84
Extract 300 6 . 2 2 依
0.23
14.22依6.09 12.35依
1.90
42.67依
4.23
32.42依
1.26
137.23依
19.92
5 5 3 . 4 3 依
77.37 18.90依0.18 0.22依0.21 83.00依8.12 1.45依0.32 0.94依1.22
Extract 500 5 . 9 8 依
0.21
12.20依3.23 12.14依
0.52
42.98依
3.12
27.89依
9.08
178.23依
6.73
5 5 2 . 1 1 依
78.23 21.22依0.21 0.23依0.11 84.12依3.8 1.79依0.45 1.24依1.98
Post-extract
(30 days)
300 6 . 1 0 依
0.20
13.34依4.23 14.50依
1.32
46.23依
2.12
32.15依
1.34
147.20依
16.72
5 1 2 . 4 0 依
66.23 19.02依1.23 0.18依0.20 82.00依7.22 2.35依0.12 0.95依1.02
Post-extract
(30 days)
500 6 . 2 4 依
0.12
14.14依2.34 14.34依
0.43
46.98依
2.13
29.09依
6.78
160.16依
6.18
5 0 2 . 9 6 依
68.23 20.19依0.99 0.19依0.12 89.01依2.34 1.99依0.12 1.34依1.21
* P <0.05, ** P <0.01,  significantly different from control.
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(Table 6 & 7). However, all the induced effects were 
reversible following withdrawal of treatment.
4. Discussion 
  Study on the effect of extract on the estrus cycle of 
rat indicating the significant increase in the length of 
diestrus phase. These findings are comparable with the 
studies of Gebrie et al[14], Pattanayak and Mazumder[10]
who had  reported antifertility effect with similar 
observations in guinea pigs, and in rats on the treatment with 
root extract of Rumex steudelii and extract of aerial parts of 
Dendrophthoe falcate. However, a significant decrease in 
the duration of proestrus and metestrus phase in the treated 
groups was recorded than those of control animals. These 
changes were found to revert back after withdrawal of the 
treatment except the proestrus phase in groups treated with 
higher group. These observations are correlated with the 
findings of Ganguly et al[15] who had reported antifertility 
effect with similar observations in mice on the treatment 
with leaf extract of Cissampelos pareira. 
  The prolongation of diestrus phase and significant decrease 
in proestrus and metestrus phase may lower the chances 
of pregnancy by interfering with the secretion of estrogen 
and progesterone because a proper estrogen/ progesterone 
balance is required for uterine receptivity to the embryo. A 
decrease in the mean number of litters in the treated groups 
is also suggesting the antifertility activity of the extract. The 
number of litters was found to decrease more with higher 
dose of treatment, which may suggest dose dependent 
antifertility effect. All the litters of treated rats grew up 
normally without having any physical abnormality indicating 
that the extract is not teratogenic. An increase in the number 
of litters observed in both the post treatment groups may 
indicate the reversible antifertility effect.
  Postcoital antifertility study showed the anti-implantation 
activity in the treated animals. The number of litters born 
due to this treatment was significantly less than controls. 
This indicates the abortifacient nature of extract which 
was evidenced by the study on abortifacient activity. Both 
response were dose dependent and increased at higher 
doses. An increase in the resorption index (%) by the extract 
is an indication of failure in the development of the embryo, 
a rate which was dose-dependent in this study. Such 
occurrence of fetal resorption suggests that interruption 
of pregnancy also occurred after implantation. These 
observations indicate the pregnancy terminating potential 
of the extract. Embryonal resorption could be due to 
modifications of uterine lining function or maternal toxicity 
which consequently may increase early resorption and late 
fetal death.  Hence, the present investigation clearly reveals 
that the extract is effective before and after the implantation 
occurred.
  In the present study, specific hormones were assayed 
based on their roles in maintaining pregnancy, since a 
failing pregnancy could be correlated to the levels of 
these hormones[16] in the body fluids. The reduction in 
the concentration of FSH is an indication of disturbance of 
estrus cycle and ovulation[15]. LH is required for continued 
development and normal function of corpora lutea. The 
significant reduction in the level of serum LH could be 
associated with the physiological process of luteolysis 
preceding parturition[16]. It could possibly be attributed 
to pregnancy failure resulting from a luteal phase that 
is not being maintained. The reduced level of hormone 
may also be due to inactivation of lutenization of ovarian 
follicles, which could be responsible for the reduction in the 
concentration of serum progesterone in this study. Elevated 
level of progesterone during pregnancy plays a key role in 
maintaining the conditions and is an important factor in the 
implantation process. Therefore, luteolysis and reduction in 
the blood levels of progesterone may contribute to abortion 
and anti-implantation activity of the P. zeylanica root extract 
in this work. These findings in the present study agree with that 
of Yakubu and Bukoye[16] on the effect of Inula viscose and 
Bambusa vulgaris leaf extract on implantation and abortion 
in rats and rabbits. In this study, an increase in prolactin 
level was observed. This finding is comparable with studies 
made by Ganguly[15] who reported that a combination of 
enhanced prolacin and suppressed LH secretion is due to 
prolongation of estrus cycle. An imbalance in endogenous 
estrogen and progesterone levels could be responsible for 
Anti-implantation activity[17]. 
  In another set of experiment on immature rats, we 
observed that the PFAE exhibited anti-estrogenic activity 
along with ethinyl estradiol as shown by the significant 
decrease in uterine weight, diameter of uterus, thickness 
of endometrium, height of endometrial epithelium and 
vaginal cornification compared with standard. These 
findings are similar to that of Ravichandran et al[18]
and Vishnukanta and Rana[2] on the effect of hydroalcoholic 
extract of Ailanthus excelsa (Roxb) stem bark and P. 
zeylanica L. leaves on uterus of female wistar rats. The 
treatment also caused a significant decrease in uterine 
content glucose, cholesterol and alkaline phosphatase 
compared with standard. This study revealed that the extract 
acted as a competitive antagonist to much more potent 
ethinyl estradiol. It is well known that for implantation 
the exact equilibrium of estrogen and progesterone 
is essential, and any disturbance in the level of these 
hormones may cause infertility[19]. The compounds having 
hormonal values usually disturb the hormonal milieu in 
the uterus and provoke an infertility effect[8]. In species 
such as rat, mouse and gerbil that exhibit facultative 
delay of implantation, nidatory estrogen secreted within 
about 24 h of initiation of implantation is necessary for 
induction of endometrial receptivity to blastocyst signal 
(s). Estrogen within a very narrow range determines the 
duration of window of uterine receptivity, and while the 
window of uterine receptivity remains open for an extended 
period at lower estrogen levels, it rapidly closes at higher 
levels. The uterine refractoriness that follows the receptive 
state at high estrogen levels is accompanied by aberrant 
endometrial expression of receptivity/implantation-related 
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genes. Based on this, careful regulation of estrogen levels 
for improvement of female fertility in in-vitro fertilization/
embryo transfer programs has been suggested[20]. Hence, 
the anti-implantation activity of the extract may also be due 
to antiestrogenic activity of extract which antagonizes the 
action of estrogen, causes structural and functional changes 
in uterus and finally decreases the implantation.   
  Nontoxicity of PFAE was evident by the unaltered 
haematological and serum clinical parameters which 
indicate normal functioning of vital organs. 
  The Phytochemical test and TLC study on PFAE revealed 
the absence of steroid and plumbagin which was removed 
by petroleum ether extraction. The root has been reported to 
be devoid of any alkaloid as confirmed by us[21]. However, 
the antifertility activity may be due to the presence of 
other phytoconstituents like glycoside, terpene and 
tannin. In conclusion, the results of this study confirm the 
reversible antifertility potentiality of PFAE of P. zeylanica 
Linn root which may be attributed, at least in part, to the 
phytoconstituents like glycoside, terpene and tannin. The 
extract has significant anti-implantation, abortifacient and 
antiestrogenic activity and is safe at the effective antifertility 
doses used in this study. It also possesses a significant effect 
on estrous cycle and hormonal level of female rats. Further 
work on isolation of active component(s) responsible for the 
antifertility activity is underway. 
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